ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHC Plant Health Care Plc

3.78
0.00 (0.00%)
Last Updated: 08:33:48
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.78 3.74 4.16 - 211,478 08:33:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.36 12.91M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.78p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 11.60p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.91 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.36.

Plant Health Care Share Discussion Threads

Showing 426 to 450 of 1350 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
11/1/2017
11:37
Anyone still following ? Starting to look like the end of the road (imo) Message I receive is that the products have not been delivering on their promise.

Declaration - Was on my watch list some years ago but I had doubts about product cost effectiveness and have just come back to have a quick look -

Agree wiht callumross above - The $65K question is " has the share price failure been due to Management and they were shoved" - or "Product and they bailed out having realised that there were minimal chances of it ever being a commercial success" ??

pugugly
14/12/2016
15:56
To lose one director in 3 months is unfortunate, to lose a CEO as well in this time is careless!
callumross
14/12/2016
12:09
Upwards from here
sajidbhandari
14/12/2016
11:32
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

Dont think so

colin12345678
13/12/2016
17:25
Is this share running out of steam or lacking in a wrong direction ??
farmsted
15/9/2016
18:23
Very quiet BB and thin trading. I wonder when is the next update or when will we hear more about the Nasdaq ipo? They already spent 1.1M on it so I guess they are committed to the ipo.
hays1
10/8/2016
12:07
you're jaundiced as a burnt bull callum, doesn't mean others have a fine chance here
dadedidodu
10/8/2016
12:07
I've held these for years but even I would be cautious at buying in at these levels. I have applied for the shares at 10p of course but all this will do is bring down my average price. Share capital will double to 140m shares once these shares are added so market cap at todays price of £35m but only £8m in cash. Funny how these people who have never posted before have suddenly appeared today which suggests a massive pump and dump operation. Be careful!
callumross
10/8/2016
11:46
From AG Pro


Plant Health Care, a provider of biological products to global agriculture markets, announced that it has signed a distribution agreement with TH Agri-Chemicals, Inc., for the use of Plant Health Care's (PHC) proprietary Harpin αβ protein technology for foliar application in sSpecialty crops in the central U.S. Commercial terms were not disclosed.

Under this agreement, TH Ag will distribute Harpin protein under the private label brand, Messenger Gold. The technology is particularly well suited to improve plant health in the specialty crops grown in TH Ag's market area.

"We are pleased to strengthen our relationship with TH Ag," said Paul Schmidt, CEO of Plant Health Care. "Long term relationships like this validate that Harpin technology improves plant health in commercially grown crops. This is another step forward in growing commercial sales of Harpin while simultaneously expanding our PREtec (Plant Response Elicitor) research programme."

"We're excited about the opportunity to expand our relationship with PHC," added Bob Zimpel, president, TH Ag. "The proprietary Harpin protein technology in Messenger Gold provides specialty growers in our market area increased yields and improves the quality of their produce. We have a track record with this technology and know how it fits into grower's production practices. The technology has clearly proven itself in the market and this agreement with PHC will grow our business as we help farmers grow theirs."

dadedidodu
10/8/2016
11:45
hxxp://www.planthealthcare.com/new-technology/

lots of sound information

dadedidodu
10/8/2016
11:44
‘PREtec’ platform
Plant Health Care is the world leader in Plant Response Elicitor technology, a class of bio-rational agricultural technology known as PREtec.

pretec-logo
PREtec elicitors selectively activate the innate growth and defense mechanisms of crop plants, leading to higher yields and better protection against pests and pathogens.

The Group’s new technology segment is focused on the invention and early development of PREtec signal peptides and the elucidation of their mode of action.

Plant Health Care has historic capabilities in this field going back to the discovery and development of Harpins, which are pathogen-derived effector molecules.

dadedidodu
10/8/2016
11:44
‘PREtec’ platform
Plant Health Care is the world leader in Plant Response Elicitor technology, a class of bio-rational agricultural technology known as PREtec.

pretec-logo
PREtec elicitors selectively activate the innate growth and defense mechanisms of crop plants, leading to higher yields and better protection against pests and pathogens.

The Group’s new technology segment is focused on the invention and early development of PREtec signal peptides and the elucidation of their mode of action.

Plant Health Care has historic capabilities in this field going back to the discovery and development of Harpins, which are pathogen-derived effector molecules.

dadedidodu
10/8/2016
11:41
top of the movers board now sky ship


This could be six bagger

abarclay
10/8/2016
11:38
24p!!! - Be very careful newcomers - note the massively dilutive placing going through at a mere 10p!
skyship
10/8/2016
11:38
lots of interest here
abarclay
10/8/2016
11:30
only 5,000 shares now avail at 25p on board
abarclay
10/8/2016
11:28
And she's away to the races
abarclay
10/8/2016
11:26
Avoid like the plague


Unmitigated disaster

abarclay
10/8/2016
11:25
MASSIVE BOWL ON CHART TO 120p
abarclay
28/7/2016
12:22
Chart and above comments appear (imo) to be saying PHC is on the way out - Not sure if any value left in the IP -
pugugly
19/6/2016
11:31
Yes - phc is a lemon!
targatarga
19/6/2016
08:38
Any news on the big drop on Friday?
leonmoon
09/4/2016
11:56
Thanks for that Thomas. Held these for a good while now and they are pretty volatile. Have you got the full broker report that you could post on here? Have considered topping up but £38m market cap seems high enough for a company that has never turned a profit and whose losses are likely to continue in the next couple years. Also, they are going to require further funding later this year. Also some of the patent protection starts to expire in 2017 (although presumably not the 3G products).
callumross
08/4/2016
14:30
Read Liberum's note on Plant Health Care (PHC), out this morning, by visiting www.research-tree.com …
“FY15 sales +9% (+15% in l.c.) with gross margins jumping to 62% from 51% last year with better product mix. A doubling R&D led to higher opex driving FY net loss to $8m vs. $6m in FY14. Net cash ended FY15 at $8.4m vs. $16.6m last year. Looking ahead we are not changing estimates materially. We expect further sales growth in existing products and R&D ramp up. PHC is excited by R&D progress and expects to introduce a 2nd peptide family for evaluation this year with trials for the 1st peptide family (Innatus 3G) going well. Innatus 3G license auctions are now expected in 2017/18. Licenses for its other peptide technologies are targeted earlier than this. We believe the recent share price fall is vastly overdone...”

thomasthetank1
17/9/2015
12:53
LONDON (Alliance News) - Liberum said the narrowed pretax profit loss reported by Plant Health Care for the first half of 2015 was in line with the broker's expectations, who retained a Hold stance on the stock. For the half year to end-June, the company reported a pretax loss of USD3.0 million, narrowed from a pretax loss of USD3.7 million, as a slight decline in revenue to USD3.2 million from USD3.3 million was offset by lower sales and marketing and administrative costs. Liberum noted that Plant Health Care, which provides biological products for the agriculture markets, "remains excited" about the prospects for the agreement the group signed with an agriculture company related to its Innatus 3G peptide platform. Innatus technology enables the design, screening and production of a large pipeline of peptides with diverse bio-stimulant properties. The peptides can provide improved yields, pest and disease resistance, and protection against abiotic stress in a wide range of crops, Plant Health Care said back in June, when the agreement was announced, with no financial details. The broker said it believes that Plant's bio-stimulant technology could be "transformational" and generate substantial revenues. However, Liberum warned that the commercial business remains loss making and the first Innatus revenues are not expected until 2017. Liberum retained its 120 pence price target. Shares in Plant Health Care were untraded Monday at 98p, having dropped by 17% year to date. By Daniel Ruiz; danielruiz@alliancenews.com Copyright 2015 Alliance News Limited. All Rights Reserved.
callumross
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock